Dexmedetomidine affects the NOX4/Nrf2 pathway to improve renal antioxidant capacity.
Yang H, Chen Y, Wang Z, Huang Y, Ma Z, Zou Y, Dong J, Zhang H, Huo M, Lv M, Liu X, Zhang G, Wang S, Yang K, Zhong P, Jiang B, Kou Y, Chen Z.
Yang H, et al. Among authors: huo m.
J Pharm Pharmacol. 2024 Apr 16:rgae044. doi: 10.1093/jpp/rgae044. Online ahead of print.
J Pharm Pharmacol. 2024.
PMID: 38625054